These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21882100)

  • 21. [Significance of blocking antibodies in the mechanism of specific desensitization therapy in patients with diffuse neurodermatitis].
    Kalamkarian AA; Samsonov VA; Nurmukhambetov ZhN
    Vestn Dermatol Venerol; 1984 May; (5):8-12. PubMed ID: 6741271
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen specific immunotherapy for atopic dermatitis.
    Novak N
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):542-46. PubMed ID: 17989532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific immunotherapy design questions.
    Moed H; de Bot C; van der Wouden JC
    Allergy; 2006 Jul; 61(7):896. PubMed ID: 16792592
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual specific immunotherapy reduces PBMC proliferations.
    Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual immunotherapy: the quest for innovative adjuvants.
    Goldman M
    Clin Exp Allergy; 2008 Nov; 38(11):1705-6. PubMed ID: 18721252
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
    Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
    Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual immunotherapy with natural rubber latex: a case report with 8-year follow-up.
    Pecora V; Aruanno A; Buonuomo A; De Pasquale T; Colagiovanni A; Sabato V; Rizzi A; Pascolini L; Ricci AG; Patriarca G; Nucera E; Schiavino D
    Contact Dermatitis; 2010 Jul; 63(1):53-4. PubMed ID: 20597936
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergen Immunotherapy for Atopic Dermatitis: Is There Room for Debate?
    Cox L; Calderon MA
    J Allergy Clin Immunol Pract; 2016; 4(3):435-44. PubMed ID: 26947461
    [No Abstract]   [Full Text] [Related]  

  • 36. Sublingual immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system.
    Gendelman SR; Lang DM
    Curr Allergy Asthma Rep; 2015 Feb; 15(2):498. PubMed ID: 25504262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
    Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
    Klein F
    MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
    [No Abstract]   [Full Text] [Related]  

  • 39. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 40. Allergen-specific sublingual immunotherapy: less mystic, more scientific.
    Bieber T
    Allergy; 2006 Feb; 61(2):149-50. PubMed ID: 16409189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.